Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis
Go back to Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis| VERACYTE (NASDAQ: VCYT) | Delayed: 39.80 -0.77 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.57 | 52 Week High | $8.45 | |||
| Open | $40.41 | 52 Week Low | $4.21 | |||
| Day High | $41.05 | P/E | N/A | |||
| Day Low | $39.55 | EPS | $-1.52 | |||
| Volume | 2,667,738 | |||||
